Using data from breast and non-small cell lung cancers they identify several clinically relevant phosphorylation modules including a cell cycle checkpoint module enriched in basal breast cancer samples and a module of PRKC isozymes putatively co-regulated by CDK12 in lung cancer. This evidence concerns the gene CDK12 and breast carcinoma.